Total planned funding: $61,937,377
Allocations
Countries/Regions
Central Asia Region | $61,937,377 |
Organizational Types
Own Agency | $23,546,626 |
Unknown | $12,234,862 |
University | $7,750,750 |
NGO | $6,456,993 |
Host Country Government Agency | $5,436,017 |
Private Contractor | $4,282,129 |
Multi-lateral Agency | $1,940,000 |
Implementing Agency | $167,000 |
Other USG Agency | $123,000 |
Program Areas
Prevention | $21,053,540 |
Management and Operations | $18,061,739 |
Governance and Systems | $10,699,484 |
Care | $6,317,969 |
Treatment | $2,940,743 |
Testing | $2,863,902 |
Budget Codes
HVMS: Management and Operations | $18,061,739 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $14,701,314 |
HBHC: Care: Adult Care and Support | $5,438,193 |
HLAB: Laboratory Infrastructure | $4,995,765 |
HVOP: Sexual Prevention: Other Sexual Prevention | $4,867,161 |
HVSI: Strategic Information | $3,350,127 |
HTXS: Treatment: Adult Treatment | $2,914,723 |
HVCT: Testing: HIV Testing and Counseling | $2,863,902 |
OHSS: Health Systems Strengthening | $2,353,592 |
HMBL: Biomedical Prevention: Blood Safety | $1,107,027 |
HVTB: Care: TB/HIV | $879,776 |
HMIN: Biomedical Prevention: Injection Safety | $378,038 |
HTXD: Treatment: ARV Drugs | $26,020 |
Top Partner Programs
USG Aggregated Agencies:
$12,407,263
Countries/Regions
Central Asia Region
2010 | $3,180,975 |
2011 | $5,099,999 |
2016 | $4,126,289 |
Not Available:
$12,234,862
Countries/Regions
Columbia University:
$7,750,750
Countries/Regions
Central Asia Region
2011 | $927,743 |
2013 | $2,374,000 |
2014 | $1,051,915 |
2016 | $3,397,092 |
U.S. Centers for Disease Control and Prevention:
$6,221,704
Countries/Regions
Central Asia Region
2013 | $3,238,500 |
2014 | $2,983,204 |
U.S. Agency for International Development:
$4,917,659
Countries/Regions
Central Asia Region
2013 | $2,538,500 |
2014 | $2,379,159 |